Wed, November 22, 2023
Tue, November 21, 2023
Mon, November 20, 2023
Sun, November 19, 2023
Fri, November 17, 2023
Thu, November 16, 2023

David Nierengarten Downgraded (TSVT) to Hold and Held Target at $2 on, Nov 20th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-2-on-nov-20th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Downgraded "2seventy bio, Inc." (TSVT) to Hold and Held Target at $2 on, Nov 20th, 2023.

David has made no other calls on TSVT in the last 4 months.



There are 5 other peers that have a rating on TSVT. Out of the 5 peers that are also analyzing TSVT, 4 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daina Graybosch of "Leerink Partners" Downgraded from Buy to Hold on, Monday, October 30th, 2023
  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Held Target at $5 on, Wednesday, September 13th, 2023
  • Kelsey Goodwin of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, September 13th, 2023
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $13 on, Friday, July 28th, 2023


This is the rating of the analyst that currently disagrees with David


  • Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $13 on, Thursday, October 12th, 2023

Publication Contributing Sources